{"id":3627,"date":"2025-12-31T13:58:58","date_gmt":"2025-12-31T13:58:58","guid":{"rendered":"https:\/\/www.lifeviz.com\/publication\/le-traitement-par-dupilumab-normalise-la-fonction-de-barriere-cutanee-chez-les-enfants-ages-de-6-a-11-ans-atteints-de-dermatite-atopique-moderee-a-severe-sanofi\/"},"modified":"2025-12-31T13:58:58","modified_gmt":"2025-12-31T13:58:58","slug":"le-traitement-par-dupilumab-normalise-la-fonction-de-barriere-cutanee-chez-les-enfants-ages-de-6-a-11-ans-atteints-de-dermatite-atopique-moderee-a-severe-sanofi","status":"publish","type":"publication","link":"https:\/\/www.lifeviz.com\/fr\/publication\/le-traitement-par-dupilumab-normalise-la-fonction-de-barriere-cutanee-chez-les-enfants-ages-de-6-a-11-ans-atteints-de-dermatite-atopique-moderee-a-severe-sanofi\/","title":{"rendered":"Le traitement par dupilumab normalise la fonction de barri\u00e8re cutan\u00e9e chez les enfants \u00e2g\u00e9s de 6 \u00e0 11 ans atteints de dermatite atopique mod\u00e9r\u00e9e \u00e0 s\u00e9v\u00e8re – Sanofi"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","categoriepublication":[],"class_list":["post-3627","publication","type-publication","status-publish","hentry"],"acf":{"type":"","mise_en_avant":false,"lien":""},"_links":{"self":[{"href":"https:\/\/www.lifeviz.com\/fr\/wp-json\/wp\/v2\/publication\/3627","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lifeviz.com\/fr\/wp-json\/wp\/v2\/publication"}],"about":[{"href":"https:\/\/www.lifeviz.com\/fr\/wp-json\/wp\/v2\/types\/publication"}],"wp:attachment":[{"href":"https:\/\/www.lifeviz.com\/fr\/wp-json\/wp\/v2\/media?parent=3627"}],"wp:term":[{"taxonomy":"categoriepublication","embeddable":true,"href":"https:\/\/www.lifeviz.com\/fr\/wp-json\/wp\/v2\/categoriepublication?post=3627"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}